Cargando…

Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus

[Image: see text] Multiple conjugation of virus-binding ligands to multivalent carriers is a prominent strategy to construct highly affine virus binders for the inhibition of viral entry into host cells. In a previous study, we introduced rationally designed sialic acid conjugates of bacteriophages...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Lutz, Müller, Eva, Ludwig, Kai, Klenk, Simon, Lauster, Daniel, Liese, Susanne, Herrmann, Andreas, Hackenberger, Christian P. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305970/
https://www.ncbi.nlm.nih.gov/pubmed/35759354
http://dx.doi.org/10.1021/acs.bioconjchem.2c00166
_version_ 1784752446368645120
author Adam, Lutz
Müller, Eva
Ludwig, Kai
Klenk, Simon
Lauster, Daniel
Liese, Susanne
Herrmann, Andreas
Hackenberger, Christian P. R.
author_facet Adam, Lutz
Müller, Eva
Ludwig, Kai
Klenk, Simon
Lauster, Daniel
Liese, Susanne
Herrmann, Andreas
Hackenberger, Christian P. R.
author_sort Adam, Lutz
collection PubMed
description [Image: see text] Multiple conjugation of virus-binding ligands to multivalent carriers is a prominent strategy to construct highly affine virus binders for the inhibition of viral entry into host cells. In a previous study, we introduced rationally designed sialic acid conjugates of bacteriophages (Qβ) that match the triangular binding site geometry on hemagglutinin spike proteins of influenza A virions, resulting in effective infection inhibition in vitro and in vivo. In this work, we demonstrate that even partially sialylated Qβ conjugates retain the inhibitory effect despite reduced activity. These observations not only support the importance of trivalent binding events in preserving high affinity, as supported by computational modeling, but also allow us to construct heterobifunctional modalities. Capsids carrying two different sialic acid ligand–linker structures showed higher viral inhibition than their monofunctional counterparts. Furthermore, capsids carrying a fluorescent dye in addition to sialic acid ligands were used to track their interaction with cells. These findings support exploring broader applications as multivalent inhibitors in the future.
format Online
Article
Text
id pubmed-9305970
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93059702022-07-23 Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus Adam, Lutz Müller, Eva Ludwig, Kai Klenk, Simon Lauster, Daniel Liese, Susanne Herrmann, Andreas Hackenberger, Christian P. R. Bioconjug Chem [Image: see text] Multiple conjugation of virus-binding ligands to multivalent carriers is a prominent strategy to construct highly affine virus binders for the inhibition of viral entry into host cells. In a previous study, we introduced rationally designed sialic acid conjugates of bacteriophages (Qβ) that match the triangular binding site geometry on hemagglutinin spike proteins of influenza A virions, resulting in effective infection inhibition in vitro and in vivo. In this work, we demonstrate that even partially sialylated Qβ conjugates retain the inhibitory effect despite reduced activity. These observations not only support the importance of trivalent binding events in preserving high affinity, as supported by computational modeling, but also allow us to construct heterobifunctional modalities. Capsids carrying two different sialic acid ligand–linker structures showed higher viral inhibition than their monofunctional counterparts. Furthermore, capsids carrying a fluorescent dye in addition to sialic acid ligands were used to track their interaction with cells. These findings support exploring broader applications as multivalent inhibitors in the future. American Chemical Society 2022-06-27 2022-07-20 /pmc/articles/PMC9305970/ /pubmed/35759354 http://dx.doi.org/10.1021/acs.bioconjchem.2c00166 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Adam, Lutz
Müller, Eva
Ludwig, Kai
Klenk, Simon
Lauster, Daniel
Liese, Susanne
Herrmann, Andreas
Hackenberger, Christian P. R.
Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
title Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
title_full Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
title_fullStr Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
title_full_unstemmed Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
title_short Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
title_sort design and functional analysis of heterobifunctional multivalent phage capsid inhibitors blocking the entry of influenza virus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305970/
https://www.ncbi.nlm.nih.gov/pubmed/35759354
http://dx.doi.org/10.1021/acs.bioconjchem.2c00166
work_keys_str_mv AT adamlutz designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT mullereva designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT ludwigkai designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT klenksimon designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT lausterdaniel designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT liesesusanne designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT herrmannandreas designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus
AT hackenbergerchristianpr designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus